| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
|
J Clin Oncol
|
2010
|
5.92
|
|
2
|
A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.
|
Nat Genet
|
2011
|
2.85
|
|
3
|
MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.
|
J Cancer Res Clin Oncol
|
2010
|
2.05
|
|
4
|
A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.93
|
|
5
|
Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
|
Biomed Pharmacother
|
2010
|
1.82
|
|
6
|
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
|
Int J Cancer
|
2010
|
1.76
|
|
7
|
Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population.
|
Int J Cancer
|
2010
|
1.49
|
|
8
|
Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population.
|
Nat Genet
|
2012
|
1.49
|
|
9
|
Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population.
|
Carcinogenesis
|
2009
|
1.48
|
|
10
|
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.
|
Med Oncol
|
2011
|
1.48
|
|
11
|
Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study).
|
Gastric Cancer
|
2014
|
1.41
|
|
12
|
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
|
Cancer Chemother Pharmacol
|
2011
|
1.39
|
|
13
|
CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
|
Gut
|
2012
|
1.22
|
|
14
|
Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.
|
PLoS One
|
2013
|
1.22
|
|
15
|
MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer.
|
Cancer Biol Ther
|
2012
|
1.14
|
|
16
|
MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
|
FEBS J
|
2012
|
1.10
|
|
17
|
Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials.
|
Future Oncol
|
2013
|
1.08
|
|
18
|
Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival.
|
Am J Respir Crit Care Med
|
2010
|
1.06
|
|
19
|
Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.
|
Clin Cancer Res
|
2012
|
1.05
|
|
20
|
A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR.
|
J Cancer Res Clin Oncol
|
2011
|
1.05
|
|
21
|
Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.
|
Biomed Pharmacother
|
2009
|
1.03
|
|
22
|
Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance.
|
Biomed Pharmacother
|
2010
|
1.02
|
|
23
|
The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
|
J Thorac Oncol
|
2010
|
1.01
|
|
24
|
A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population.
|
Clin Cancer Res
|
2010
|
0.99
|
|
25
|
Targeting sarcoplasmic/endoplasmic reticulum Ca²+-ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma.
|
Mol Cancer Ther
|
2011
|
0.99
|
|
26
|
Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk.
|
PLoS One
|
2013
|
0.99
|
|
27
|
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
|
Cancer Biol Ther
|
2012
|
0.99
|
|
28
|
JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells.
|
Biomed Pharmacother
|
2009
|
0.98
|
|
29
|
Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.
|
Am J Hum Genet
|
2012
|
0.98
|
|
30
|
Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in mice.
|
Clin Immunol
|
2009
|
0.97
|
|
31
|
Meta-analysis on the association between nonsteroidal anti-inflammatory drug use and lung cancer risk.
|
Clin Lung Cancer
|
2011
|
0.97
|
|
32
|
Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
|
Clin Lung Cancer
|
2011
|
0.96
|
|
33
|
NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer.
|
Biochim Biophys Acta
|
2013
|
0.95
|
|
34
|
The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.
|
J Cancer Res Clin Oncol
|
2012
|
0.95
|
|
35
|
miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
|
Int J Mol Med
|
2013
|
0.95
|
|
36
|
The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
|
PLoS One
|
2012
|
0.95
|
|
37
|
Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
|
Mol Carcinog
|
2011
|
0.94
|
|
38
|
A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
|
Int Immunol
|
2009
|
0.93
|
|
39
|
Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells.
|
Biomed Pharmacother
|
2008
|
0.92
|
|
40
|
Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation.
|
Anticancer Drugs
|
2011
|
0.92
|
|
41
|
Clinical perspective of afatinib in non-small cell lung cancer.
|
Lung Cancer
|
2013
|
0.91
|
|
42
|
Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
|
Lung Cancer
|
2011
|
0.90
|
|
43
|
Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.
|
Carcinogenesis
|
2010
|
0.90
|
|
44
|
Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese.
|
PLoS Genet
|
2013
|
0.90
|
|
45
|
Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
|
Cancer Chemother Pharmacol
|
2013
|
0.90
|
|
46
|
Sequential transcatheter arterial chemoembolization, three-dimensional conformal radiotherapy, and high-intensity focused ultrasound treatment for unresectable hepatocellular carcinoma patients.
|
J Biomed Res
|
2012
|
0.89
|
|
47
|
Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
|
Cancer Chemother Pharmacol
|
2013
|
0.89
|
|
48
|
Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
|
Tumour Biol
|
2014
|
0.89
|
|
49
|
miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1.
|
Pathol Oncol Res
|
2013
|
0.88
|
|
50
|
CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.
|
Cell Cycle
|
2009
|
0.88
|
|
51
|
Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
|
Lung Cancer
|
2010
|
0.87
|
|
52
|
Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib.
|
Biomed Pharmacother
|
2012
|
0.86
|
|
53
|
A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
|
PLoS One
|
2013
|
0.86
|
|
54
|
Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis.
|
Future Oncol
|
2014
|
0.86
|
|
55
|
Can plasma DNA monitoring be employed in personalized chemotherapy for patients with advanced lung cancer?
|
Biomed Pharmacother
|
2012
|
0.86
|
|
56
|
Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.
|
PLoS One
|
2013
|
0.85
|
|
57
|
Genome-wide association study of survival in early-stage non-small cell lung cancer.
|
Ann Surg Oncol
|
2014
|
0.85
|
|
58
|
Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer.
|
BMC Cancer
|
2011
|
0.85
|
|
59
|
Aurora kinase inhibition induces PUMA via NF-κB to kill colon cancer cells.
|
Mol Cancer Ther
|
2014
|
0.84
|
|
60
|
miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
|
Anticancer Agents Med Chem
|
2014
|
0.83
|
|
61
|
Efficacy of therapy with bortezomib in solid tumors: a review based on 32 clinical trials.
|
Future Oncol
|
2014
|
0.83
|
|
62
|
Integrin α6(high) cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma.
|
Mol Cancer Ther
|
2011
|
0.83
|
|
63
|
Paeoniflorin modulates multidrug resistance of a human gastric cancer cell line via the inhibition of NF-κB activation.
|
Mol Med Rep
|
2011
|
0.82
|
|
64
|
Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity.
|
Anticancer Drugs
|
2014
|
0.82
|
|
65
|
Enhanced charge transfer by gold nanoparticle at DNA modified electrode and its application to label-free DNA detection.
|
ACS Appl Mater Interfaces
|
2014
|
0.81
|
|
66
|
WT1 promotes invasion of NSCLC via suppression of CDH1.
|
J Thorac Oncol
|
2013
|
0.81
|
|
67
|
Double recognition of oligonucleotide and protein in the detection of DNA methylation with surface plasmon resonance biosensors.
|
Biosens Bioelectron
|
2010
|
0.81
|
|
68
|
The property of methylated APC gene promotor and its influence on lung cancer cell line.
|
Biomed Pharmacother
|
2008
|
0.81
|
|
69
|
Candidate variants at 6p21.33 and 6p22.1 and risk of non-small cell lung cancer in a Chinese population.
|
Int J Mol Epidemiol Genet
|
2009
|
0.81
|
|
70
|
Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective study.
|
J Chemother
|
2015
|
0.80
|
|
71
|
Detection of microRNA SNPs with ultrahigh specificity by using reduced graphene oxide-assisted rolling circle amplification.
|
Chem Commun (Camb)
|
2015
|
0.80
|
|
72
|
Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.
|
Biomed Pharmacother
|
2008
|
0.80
|
|
73
|
Loss of SHP-2 activity in CD4+ T cells promotes melanoma progression and metastasis.
|
Sci Rep
|
2013
|
0.80
|
|
74
|
Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer.
|
Biomed Pharmacother
|
2013
|
0.79
|
|
75
|
TNF-α-308 G>A polymorphism and colorectal cancer risk: a meta-analysis.
|
Int J Colorectal Dis
|
2012
|
0.79
|
|
76
|
An electrochemical alkaline phosphatase biosensor fabricated with two DNA probes coupled with λ exonuclease.
|
Biosens Bioelectron
|
2011
|
0.79
|
|
77
|
Phase II study of weekly irinotecan plus cisplatin in patients with previously untreated extensive-stage extrapulmonary small cell carcinoma.
|
Onkologie
|
2011
|
0.79
|
|
78
|
Clinical significance of PIK3CA and survivin in primary adenosquamous lung carcinoma.
|
Med Oncol
|
2014
|
0.78
|
|
79
|
Genetic variants in one-carbon metabolism-related genes contribute to NSCLC prognosis in a Chinese population.
|
Cancer
|
2010
|
0.78
|
|
80
|
Thermal analysis in the rat glioma model during directly multipoint injection hyperthermia incorporating magnetic nanoparticles.
|
J Nanosci Nanotechnol
|
2011
|
0.78
|
|
81
|
Effect of gefitinib challenge to initial treatment with non-small cell lung cancer.
|
Biomed Pharmacother
|
2011
|
0.78
|
|
82
|
A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
|
Biomed Pharmacother
|
2008
|
0.77
|
|
83
|
The study on newly developed McAb NJ001 specific to non-small cell lung cancer and its biological characteristics.
|
PLoS One
|
2012
|
0.77
|
|
84
|
An electrochemical biosensor for clenbuterol detection and pharmacokinetics investigation.
|
Talanta
|
2013
|
0.77
|
|
85
|
[Effect of recombinant adenovirus-p53 on growth and chemosensitivity of human lung adenocarcinoma cell lines].
|
Zhongguo Fei Ai Za Zhi
|
2006
|
0.77
|
|
86
|
Highly sensitive protein detection based on a novel probe with catalytic activity combined with a signal amplification strategy: assay of MDM2 for cancer staging.
|
Chem Commun (Camb)
|
2013
|
0.76
|
|
87
|
[Current status and prospects of maintenance therapy in advanced stage non-small cell lung cancer].
|
Zhongguo Fei Ai Za Zhi
|
2010
|
0.76
|
|
88
|
Xiao-Ai-Ping, a TCM Injection, Enhances the Antigrowth Effects of Cisplatin on Lewis Lung Cancer Cells through Promoting the Infiltration and Function of CD8(+) T Lymphocytes.
|
Evid Based Complement Alternat Med
|
2013
|
0.75
|
|
89
|
CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.
|
Med Oncol
|
2015
|
0.75
|
|
90
|
A simple and general approach to assay protease activity with electrochemical technique.
|
Biosens Bioelectron
|
2013
|
0.75
|
|
91
|
[Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer.].
|
Zhongguo Fei Ai Za Zhi
|
2009
|
0.75
|
|
92
|
[microRNA expression profiling of side population cells in human lung cancer and preliminary analysis].
|
Zhongguo Fei Ai Za Zhi
|
2010
|
0.75
|
|
93
|
Pemetrexed-carboplatin with intercalated icotinib in the treatment of patient with advanced EGFR wild-type lung adenocarcinoma: A case report.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
94
|
Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma.
|
J Chemother
|
2012
|
0.75
|
|
95
|
Delivery of paclitaxel and berbamine by polymeric carriers to cure gastric cancer.
|
Oncol Res
|
2013
|
0.75
|
|
96
|
Andrographolide enhances cisplatin-mediated anticancer effects in lung cancer cells through blockade of autophagy.
|
Anticancer Drugs
|
2017
|
0.75
|
|
97
|
Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema.
|
Anticancer Drugs
|
2017
|
0.75
|